Lifecore Biomedical Inc Share Price Today: Live Updates & Key Insights

Lifecore Biomedical Inc share price today is $4.02, up -0.99%. The stock opened at $3.96 against the previous close of $4.06, with an intraday high of $4.05 and low of $3.91.

Lifecore Biomedical Inc Share Price Chart

Lifecore Biomedical Inc

us-stock
To Invest in {{usstockname}}
us-stock

Lifecore Biomedical Inc Share Price Performance

$4.02 -0.0099(-0.99%) LFCR at 23 Mar 2026 01:57 PM Drug Manufacturers - Specialty & Generic
Lowest Today 3.91
Highest Today 4.05
Today’s Open 3.96
Prev. Close 4.06
52 Week High 8.98
52 Week Low 3.90
Day’s Range: Low 3.91 High 4.05
52-Week Range: Low 3.90 High 8.98
1 day return -
1 Week return -7.79
1 month return -45.0
3 month return -50.79
6 month return -48.98
1 year return -38.81
3 year return +23.69
5 year return -63.65
10 year return -

Lifecore Biomedical Inc Institutional Holdings

Wynnefield Capital Inc 12.55

Legion Partners Asset Management, LLC 11.91

Greenhaven Road Investment Management, L.P. 9.83

325 Capital LLC 5.77

BlackRock Inc 4.91

Vanguard Group Inc 4.47

Vanguard Total Stock Mkt Idx Inv 2.19

Geode Capital Management, LLC 2.08

Morgan Stanley - Brokerage Accounts 1.89

iShares Russell 2000 ETF 1.75

State Street Corp 1.44

DCF Advisers, LLC 1.18

Vanguard Institutional Extnd Mkt Idx Tr 1.09

Fidelity Small Cap Index 0.72

Millennium Management LLC 0.67

Northern Trust Corp 0.64

Fidelity Extended Market Index 0.52

Quinn Opportunity Partners LLC 0.49

iShares Russell 2000 Growth ETF 0.44

Tocqueville Asset Management L.P. 0.40

Vanguard Russell 2000 ETF 0.35

State St Russell Sm/Mid Cp® Indx SL Cl I 0.33

Royal Bank of Canada 0.33

SSgA Russell Small Cap Completeness Idx 0.33

Jane Street Group LLC 0.32

LPL Financial Corp 0.30

Marshall Wace Asset Management Ltd 0.30

Squarepoint Ops LLC 0.29

Susquehanna International Group, LLP 0.27

State St Russell Sm Cap® Indx SL Cl I 0.24

Delafield Concentrated Value 0.24

Blackrock Extended Mkt Fund CF 0.22

1290 VT GAMCO Small Company Value IB 0.21

iShares Micro-Cap ETF 0.19

Extended Equity Market Fund K 0.19

Fidelity Total Market Index 0.19

Schwab Small Cap Index 0.18

iShares Russell 2000 Value ETF 0.17

NT R2000 Index Fund - NL 0.17

Bridgeway Ultra-Small Company Market 0.15

Lifecore Biomedical Inc Market Status

Strong Buy: 2

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

Lifecore Biomedical Inc Fundamentals

Market Cap 150.66 M

PB Ratio 192.0992

PE Ratio 0.0

Enterprise Value 275.80 M

Total Assets 239.34 M

Volume 793364

Lifecore Biomedical Inc Company Financials

Annual Revenue FY25:128867000 128.9M, FY24:128261000 128.3M, FY23:185786000 185.8M, FY22:185786000 185.8M, FY21:544161000 544.2M

Annual Profit FY25:40298000 40.3M, FY24:41850000 41.9M, FY23:50553000 50.6M, FY22:50370000 50.4M, FY21:81474000 81.5M

Annual Net worth FY25:-38717000 -38.7M, FY24:12013000 12.0M, FY23:-46084000 -46.1M, FY22:-97431000 -97.4M, FY21:-32665000 -32.7M

Quarterly Revenue Q1/2026:44412000 44.4M, Q3/2025:31109000 31.1M, Q2/2025:36444000 36.4M, Q1/2025:35154000 35.2M, Q4/2024:32564000 32.6M

Quarterly Profit Q1/2026:12762000 12.8M, Q3/2025:7791000 7.8M, Q2/2025:13982000 14.0M, Q1/2025:9845000 9.8M, Q4/2024:11084000 11.1M

Quarterly Net worth Q1/2026:-7970000 -8.0M, Q3/2025:-9991000 -10.0M, Q2/2025:-1147000 -1.1M, Q1/2025:-14769000 -14.8M, Q4/2024:-6571000 -6.6M

About Lifecore Biomedical Inc & investment objective

Company Information Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

Organisation Drug Manufacturers - Specialty & Generic

Employees 400

Industry Drug Manufacturers - Specialty & Generic

CEO Mr. Paul Josephs

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Lifecore Biomedical Inc FAQs

What is the share price of Lifecore Biomedical Inc today?

The current share price of Lifecore Biomedical Inc is $4.02.

Can I buy Lifecore Biomedical Inc shares in India?

Yes, Indian investors can buy Lifecore Biomedical Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Lifecore Biomedical Inc shares in India?

You can easily invest in Lifecore Biomedical Inc shares from India by:

Can I buy fractional shares of Lifecore Biomedical Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Lifecore Biomedical Inc?

Lifecore Biomedical Inc has a market cap of $150.66 M.

In which sector does Lifecore Biomedical Inc belong?

Lifecore Biomedical Inc operates in the Drug Manufacturers - Specialty & Generic sector.

What documents are required to invest in Lifecore Biomedical Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Lifecore Biomedical Inc?

The PE ratio of Lifecore Biomedical Inc is N/A and the PB ratio is 192.10.